Pohl, M. O., Busnadiego, I., Marrafino, F., Wiedmer, L., Hunziker, A., Fernbach, S., … Stertz, S. (2021). Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivir. Journal of General Virology, 102(7). https://doi.org/10.1099/jgv.0.001625 (Original work published)

Unzue, A., Lafleur, K., Zhao, H., Zhou, T., Dong, J., Kolb, P., … Nevado, C. (2016). Three stories on Eph kinase inhibitors: From in silico discovery to in vivo validation. European Journal of Medicinal Chemistry, 112, 347-366. https://doi.org/10.1016/j.ejmech.2016.01.057 (Original work published)

Zhao, H., & Caflisch, A. (2014). Discovery of dual ZAP70 and Syk kinases inhibitors by docking into a rare C-helix-out conformation of Syk. Bioorganic & Medicinal Chemistry Letters, 24(6), 1523-1527. https://doi.org/10.1016/j.bmcl.2014.01.083 (Original work published)

Zhou, T., Georgeon, S., Moser, R., Moore, D. J., Caflisch, A., & Hantschel, O. (2014). Specificity and mechanism-of-action of the JAK2 tyrosine kinase inhibitors ruxolitinib and SAR302503 (TG101348). Leukemia, 28(2), 404-407. https://doi.org/10.1038/leu.2013.205 (Original work published 2014)

Zhao, H., & Caflisch, A. (2013). Discovery of ZAP70 inhibitors by high-throughput docking into a conformation of its kinase domain generated by molecular dynamics. Bioorganic & Medicinal Chemistry Letters, 23(20), 5721-5726. https://doi.org/10.1016/j.bmcl.2013.08.009 (Original work published)

Zhao, H., Huang, D., & Caflisch, A. (2012). Discovery of tyrosine kinase inhibitors by docking into an inactive kinase conformation generated by molecular dynamics. ChemMedChem, 7(11), 1983-1990. https://doi.org/10.1002/cmdc.201200331 (Original work published 2012)

Zhou, T., & Caflisch, A. (2010). High-throughput virtual screening using quantum mechanical probes: Discovery of selective kinase inhibitors. ChemMedChem, 5(7), 1007-1014. https://doi.org/10.1002/cmdc.201000085 (Original work published)

Huang, D., Zhou, T., Lafleur, K., Nevado, C., & Caflisch, A. (2010). Kinase selectivity potential for inhibitors targeting the ATP binding site: A network analysis. Bioinformatics, 26(2), 198-204. https://doi.org/10.1093/bioinformatics/btp650 (Original work published)

Lafleur, K., Huang, D., Zhou, T., Caflisch, A., & Nevado, C. (2009). Structure-based optimization of potent and selective inhibitors of the tyrosine kinase erythropoietin producing human hepatocellular carcinoma receptor B4 (EphB4). Journal of Medicinal Chemistry, 52(20), 6433-6446. https://doi.org/10.1021/jm9009444 (Original work published)

Kolb, P., Kipouros, C. B., Huang, D., & Caflisch, A. (2008). Structure-based tailoring of compound libraries for high-throughput screening: Discovery of novel EphB4 kinase inhibitors. Proteins: Structure, Function, and Bioinformatics, 73(1), 11-18. https://doi.org/10.1002/prot.22028 (Original work published 2008)